NCT00890994View on ClinicalTrials.gov

Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 19, 2009

Primary Completion Date

November 14, 2014

Study Completion Date

November 14, 2016

Conditions
Breast Cancer
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT00890994 - Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS) | Biotech Hunter | Biotech Hunter